Structure and function of complement C5 convertase enzymes

MK Pangburn, N Rawal - Biochemical Society Transactions, 2002 - portlandpress.com
The multisubunit enzymes of the complement system that cleave C5 have many unusual
properties, the most striking of which is that they acquire their specificity for C5 following …

Structural basis for therapeutic inhibition of complement C5

MM Jore, S Johnson, D Sheppard, NM Barber… - Nature structural & …, 2016 - nature.com
Activation of complement C5 generates the potent anaphylatoxin C5a and leads to pathogen
lysis, inflammation and cell damage. The therapeutic potential of C5 inhibition has been …

Structure, function and control of complement C5 and its proteolytic fragments

N S. Laursen, F Magnani… - Current molecular …, 2012 - benthamdirect.com
… Functional role of the noncatalytic subunit of complement C5 convertase. J Immunol 2000; …
The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA…

A novel role of complement: mice deficient in the fifth component of complement (C5) exhibit impaired liver regeneration

D Mastellos, JC Papadimitriou, S Franchini… - The Journal of …, 2001 - journals.aai.org
Components of innate immunity have recently been implicated in the regulation of
developmental processes. Most strikingly, complement factors appear to be involved in limb …

Complement C5 protein as a marker of subclinical atherosclerosis

D Martínez-López, R Roldan-Montero… - Journal of the American …, 2020 - jacc.org
… Plasma levels of complement C5 were analyzed in relation to the presence of generalized
(>2 plaques) or incipient (0 to 2 plaques) subclinical atherosclerosis in 2 independent clinical …

Complement C5 mediates experimental tubulointerstitial fibrosis

P Boor, A Konieczny, L Villa, AL Schult… - Journal of the …, 2007 - journals.lww.com
Renal fibrosis is the final common pathway of most progressive renal diseases. C5 was
recently identified as a risk factor for liver fibrosis. This study investigated the role of C5 in the …

Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia.

PR Craddock, D Hammerschmidt, JG White… - The Journal of clinical …, 1977 - jci.org
Activated plasma complement will induce biphasic aggregation of human granulocytes
dectable by standard nephelometric techniques. The responsible active component was …

Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19

J Laurence, JJ Mulvey, M Seshadri, A Racanelli… - Clinical …, 2020 - Elsevier
Respiratory failure and acute kidney injury (AKI) are associated with high mortality in SARS-CoV-2-associated
Coronavirus disease 2019 (COVID-19). These manifestations are linked …

Primary complement C5 deficiencies–molecular characterization and clinical review of two families

L Schejbel, D Fadnes, H Permin, KT Lappegård… - Immunobiology, 2013 - Elsevier
… All activation pathways lead to generation of a C3 convertase, and subsequently to formation
of a complement C5 convertase which cleaves C5 into C5a (residues 678–751) and C5b. …

The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria

A Röth, J Nishimura, Z Nagy… - Blood, The Journal …, 2020 - ashpublications.org
Complement C5 inhibition is the standard of care (SoC) for patients with paroxysmal
nocturnal hemoglobinuria (PNH) with significant clinical symptoms. Constant and complete …